A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine

被引：0
作者：
Kotoe Takayoshi
Kosuke Sagara
Keita Uchino
Hitoshi Kusaba
Naotaka Sakamoto
Atsushi Iguchi
Eishi Baba
机构：
[1] Clinical Research Institute,Department of Medical Oncology
[2] National Hospital Organization Kyushu Medical Center,Department of Medicine and Biosystemic Science
[3] Kyushu University Graduate School of Medical Sciences,Department of Urology
[4] National Hospital Organization Kyushu Medical Center,Department of Comprehensive Clinical Oncology
[5] Faculty of Medical Sciences,undefined
[6] Kyushu University,undefined
来源：
BMC Cancer | / 15卷
关键词：
ABCB1; Adverse event; Bile duct carcinoma; Gemcitabine; Plasma concentration; Renal cell carcinoma; Sunitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Prostatic Metastasis of Renal Cell Carcinoma Successfully Treated with Sunitinib
    Fokt, Ralf-Michael
    Templeton, Arnoud
    Gillessen, Silke
    Oehlschlegel, Christian
    Schmid, Hans-Peter
    UROLOGIA INTERNATIONALIS, 2009, 83 (01) : 122 - 124
  • [42] Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma
    Nachbargauer, Sebastian
    Bruchbacher, Andreas
    Fajkovic, Harun
    Remzi, Mesut
    Schmidinger, Manuela
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : E277 - E283
  • [43] Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency
    Poprach, Alexandr
    Bortlicek, Zbynek
    Melichar, Bohuslav
    Lakomy, Radek
    Svoboda, Marek
    Kiss, Igor
    Zemanova, Milada
    Fiala, Ondrej
    Kubackova, Katerina
    Coufal, Oldrich
    Pavlik, Tomas
    Dusek, Ladislav
    Vyzula, Rostislav
    Buchler, Tomas
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (04) : 507 - 513
  • [44] Sunitinib Dose Escalation in Metastatic Renal Cell Carcinoma
    Bruchbacher, Andreas
    Nachbargauer, Sebastian
    Fajkovic, Harun
    Schmidinger, Manuela
    KIDNEY CANCER, 2019, 3 (02) : 103 - 110
  • [45] Effect of dasatinib on blood concentrations of sunitinib and adverse events in a patient with metastatic renal cell carcinoma treated with sunitinib: A case report
    Sato, Miki Takenaka
    Yashima, Hideaki
    Araki, Takuya
    Nomura, Masashi
    Suzuki, Kazuhiro
    Yamamoto, Koujirou
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2025, 29 (04)
  • [46] The Impact of Tumor Burden Characteristics in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
    Basappa, Naveen S.
    Elson, Paul
    Golshayan, Ali-Reza
    Wood, Laura
    Garcia, Jorge A.
    Dreicer, Robert
    Rini, Brian I.
    CANCER, 2011, 117 (06) : 1183 - 1189
  • [47] Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
    M Gilabert
    M Provansal
    M Cappiello
    Y Walz
    N Salem
    C Tarpin
    S Brunelle
    J Thomassin
    G Gravis
    British Journal of Cancer, 2013, 109 : 1750 - 1754
  • [48] Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy
    Katta, Anilkumar
    Fesler, Mark J.
    Tan, Alan
    Vuong, Giao
    Richart, John M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 409 - 412
  • [49] Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy
    Anilkumar Katta
    Mark J. Fesler
    Alan Tan
    Giao Vuong
    John M. Richart
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 409 - 412
  • [50] Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
    Yildiz, Ibrahim
    Sen, Fatma
    Kilic, Leyla
    Ciftci, Rumeysa
    Basaran, Mert
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (01) : 74 - 76
12345